<div class="p4l_caption"><div class="p4l_captionTitle"><a target="_blank" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3015011/" ref="ordinalpos=1048&amp;ncbi_uid=3605545&amp;link_uid=PMC3015011" image-link="/pmc/articles/PMC3015011/figure/F6/" class="imagepopup">Figure 6.  From: Novel Chemical Suppressors of Long QT Syndrome Identified by an in vivo Functional Screen. </a></div><br /><div class="p4l_captionBody">Flurandrenolide acts via the glucocorticoid signaling pathway. (a) Dose-response curve using steroids known to act through specific signaling pathways: dexamethasone (glucocorticoid pathway), testosterone (androgen pathway), and DOCA (mineralocorticoid pathway). (b) Knockdown of the glucocorticoid receptor blocks rescue of long QT by flurandrenolide and dexamethasone (n= 26â€“31).</div></div>